Clinical Data Strategy and AI Innovation
Transforming Clinical Trials through Smarter Data and AI
14/10/2025 - 15 October 2025 ALL TIMES CET (UTC +2h)
As clinical data volume and complexity continue to grow, effective data management and advanced analytics have become critical for trial success. AI-driven innovations are opening new opportunities to streamline workflows, enhance data quality, and accelerate insights across the development lifecycle. SCOPE’s Clinical Data and AI Innovation conference explores the evolving landscape of clinical trials, with a focus on data integration, large-scale R&D governance, and the strategic application of AI and GenAI. Industry leaders will discuss how to break traditional data silos and optimize trial timelines through technology, as well as share strategies for data collaboration, smarter data collection practices, and innovative AI applications in clinical trials and real-world data. Case studies, interactive panel discussions, co-presentations, and data sharing will further enrich the value attendees gain from the gathering.

Monday, 13 October

Registration Open

MONDAY AFTERNOON WORKSHOPS & USER GROUP (IN-PERSON ONLY)

– 15:15 WORKSHOP 1: Nuts and Bolts of AI Implementation: What to Avoid and What to Emphasise (Sponsorship Opportunity Available)

INSTRUCTORS:
Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany
Prasanna Rao, Chief Products and Innovation Officer, Saama
This interactive workshop will provide a practical overview of key considerations for implementing AI in clinical operations and beyond. Topics will include ethical implications and regulatory updates such as the EU AI Act, a clear explanation of AI APIs and how they function, and best practices for effective prompt engineering. Attendees will gain valuable insights into common pitfalls to avoid and strategies to successfully integrate AI tools in a regulated environment.

– 17:00 USER GROUP: Citeline Industry Roundtable (Invitation Only)

– 17:00 WORKSHOP 2: Modernising Informed Consent: AI, Automation, and Ethics in Global Clinical Trials

INSTRUCTORS:

Pooja Bholanath Pagare, Manager, Clinical Development, ZS Associates

Kirstin Goldring, Senior Director/Head, HBS Compliance and Governance, AstraZeneca

Sofiane Nacia, Director, Senior Global Process Owner, Novartis

Hilde Vanaken, Head EFGCP eConsent Initiative, EFGCP – European Forum for Good Clinical Practice

Brenda Yanak, Former Vice President, Bristol Myers Squibb Co.; Founder, Clinical Transformation Partners LLC​

As clinical trials grow in complexity and scale, the role of informed consent becomes more critical—and more challenging—than ever. This interactive workshop explores the evolving landscape of consent in the digital age, from the automation of consent form development to navigating global ethics and privacy regulations. We'll examine the responsibilities embedded in consent language, new international policies designed to uphold participant rights, and the use of AI-powered tools to review, manage, and search consent documents for transparency and compliance. Designed for the broader clinical operations community, this session will be especially valuable for professionals focused on consent processes, patient recruitment, study start-up, site activation, decentralised trials, clinical technology, and clinical data. Attendees will leave with actionable insights into how technology can safeguard ethics while streamlining consent workflows across diverse trial environments.

– 18:45 WORKSHOP 3: Tackling Kit Wastage for Greener Clinical Trials (Sponsorship Opportunity Available)

INSTRUCTORS:

Michael J. Cohen, MSc, MBA, SEP, Senior Director, Lead, Environmental Sustainability, Thermo Fisher Scientific
Thierry Escudier, Portfolio Lead, Pistoia Alliance
Celine Gervais, CEO, Quipment SAS 
Peter Morley, Clinical Sustainability Manager, Process Transformation & Digitalization, Novo Nordisk A/S
Diana Steinbuesch, Founding Member, Biospecimen Management Consortium (BMC); BioX Operations Portfolio Lead (Oncology), Roche

ESG (Environmental, Social, & Governance) Leaders in Pharma & Sustainable Trials Workshop at SCOPE. Join us for an insightful workshop on optimising clinical trial supply management. Discover strategies to minimise supply overage and kit wastage, while enhancing environmental sustainability. Learn from industry experts how to implement best practices that reduce waste, lower costs, and reduce greenhouse gas emissions in clinical trials. This workshop is essential for professionals committed to improving efficiency and sustainability in clinical research.​

Tuesday, 14 October

MORNING COFFEE AND CONFERENCE SESSIONS

SCOPE Europe Fun Run

RUN COORDINATORS: 

Bridget Kotelly, Senior Conference Director, Cambridge Healthtech Institute
Eileen Murphy, Conference Producer, Production, Cambridge Healthtech Institute
Join SCOPE’s Coordinators on Tuesday morning for our Rise and Shine Fun Run! Don’t forget to pack your sneakers. All of us at Cambridge Healthtech Institute recognizse the importance of integrating well-being and fitness into our work travel routines. We're excited to offer our support to faculty, sponsors, and attendees in fostering a culture of wellness. This is an easygoing, informal running (or walking) event. No time chips, running bibs, or energy bars—just a laid-back opportunity for a small group to start the day on a positive note. You can sprint, run, jog, walk, jog-and-talk, or walk-and-talk—the goal is to get up and get moving! Meet us in the front lobby near the concierge at 6:45 am sharp! 

Registration and Morning Coffee

DATA VISUALISATION AND AI TO RESHAPE STUDY CONDUCT

How to Work with Stakeholders to Define and Build a Clinical Control Tower

Photo of Philip Brown, Director, Data Visualization and Application Development, Biogen , Director, Data Visualization and Application Development , Biogen
Philip Brown, Director, Data Visualization and Application Development, Biogen , Director, Data Visualization and Application Development , Biogen
Photo of Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen
Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen

This session explores how to engage cross-functional stakeholders to define, design, and implement a Clinical Control Tower—a centralized framework that enables real-time trial oversight and smarter decision-making. Attendees will learn strategies for aligning teams, selecting key data signals, and driving operational efficiency through integrated analytics, ultimately enhancing visibility, collaboration, and performance across the clinical trial lifecycle.

Enhancing Clinical Trials: Leveraging Clinical Operations Data with AI Innovations for Improved Decision-Making

Photo of Anna Majewska, Head of Product Experience, Evinova , Head of Product Experience , Evinova
Anna Majewska, Head of Product Experience, Evinova , Head of Product Experience , Evinova

In the evolving landscape of clinical trials, integrating clinical operations data with AI technologies is revolutionizing decision-making processes. This presentation highlights an innovative solution, showcasing real-life examples of enhanced trial efficiency and effectiveness through data integration and analysis. By envisioning a future with increased automation and machine learning, we explore the potential these technologies hold for optimising the industry, paving the way for more informed and agile clinical trials.

Grand Opening Coffee Break in the Exhibit Hall

The SCOPE Europe Exhibit Hall is the best place to fuel up with a mid-morning coffee while visiting with our many exhibitors. Learn about what’s new in the industry, connect with colleagues and partners, and make some new friends.

TUESDAY MORNING PLENARY SESSION: ACCELERATING THE FUTURE OF CLINICAL TRIALS: AI, EXECUTION, AND COLLABORATIVE DESIGN

Grab Your Seat: Plenary Keynote Seat Raffle & Prize Giveaway!* 

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

*Must be present to win!

Welcome to SCOPE Europe—Who Is Here and Why?

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

KEYNOTE PRESENTATION:
Transformative AI: Shaping the Future of Healthcare

James Weatherall, PhD, Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca , VP & Chief Data Scientist , BioPharmaceuticals R&D , AstraZeneca

Artificial intelligence is transforming medicines development, paving the way for enhanced patient outcomes and organisational success. By deriving actionable insights from complex datasets, we are accelerating the discovery of novel targets, elucidating intricate disease mechanisms, and improving how we approach clinical trials. The vast and exciting future applications of AI will deliver the next frontier in healthcare, urging us to reimagine innovation and advance science, with the goal of bringing new, better medicines to patients, faster.

Meet Your Neighbor: What Is YOUR Biggest Technological or Operational Challenge Right Now?

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

KEYNOTE CASE STUDY CO-PRESENTATION:
Learning from Lightspeed Execution of the OCEANIC STROKE Program

Alexander Krupp, PhD, Vice President, Executive Clinical Program Excellence Lead, Bayer AG , VPq , Executive Clinical Program Excellence Lead , Bayer AG

Georgios Tsivgoulis, MD, PhD, Professor of Neurology, National & Kapodistrian University Of Athens; President, Hellenic Neurological Society , Professor of Neurology , University of Athens

More than 14 million patients experience a stroke every year. Preventing as many stroke events as possible will retain a high quality of life for patients, their caregivers, and society—and is therefore of high relevance. For Bayer’s OCEANIC program in stroke, we have established a product-centric operational model that has resulted in the competitor feedback: “You are killing us with excellence—how are you doing this?” In this keynote, we will explore how our industry can learn from high performance operating models to serve our patients faster, better, and at lower cost.

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
Closing the Gap between Protocol Development and Feasibility to Ensure Downstream Success with Sites and Patients

Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine , Executive Director and Professor, Tufts Center for the Study of Drug Development. , Tufts University School of Medicine

Panelists:

Bernhard Glombitza, Head, Clinical Operations EMEA and LATAM, Bayer , Head Clinical Customer Engagement and Clinical Operations EMEA/LATAM , Clinical Development & Operations , Bayer

Christian Milliet, Head of Site & Healthcare Ambassadors, Clinical Development Operations, CSL Behring , Head of Site & Healthcare Ambassadors , Clinical Development Operations , CSL Behring

Susana Ramos, PhD, Global Early Planning TA Lead, Clinical Sciences & Operations, Sanofi , Global Early Planning TA Lead , Clinical Sciences & Operations , Sanofi Grp

Matthieu Ruffin, Head Study Leadership, SSO GCO Development, Novartis , Head Study Leadership , SSO GCO Development , Novartis

Join Your Peers for a Networking Luncheon in the Exhibit Hall

Take this opportunity to refresh and refuel with our Exhibit Hall lunch. Enjoy good food and even better conversation during our walk and talk luncheon.

AI INNOVATION

Chairperson's Remarks 

Farrell Healion, Founder & Principal Consultant, OptiTrial , Founder & Principal Consultant , OptiTrial

Smarter Trials, Faster Setups: Unlocking Clinical Operations with AI-Created Study Assets

Photo of Farrell Healion, Founder & Principal Consultant, OptiTrial , Founder & Principal Consultant , OptiTrial
Farrell Healion, Founder & Principal Consultant, OptiTrial , Founder & Principal Consultant , OptiTrial

AI is transforming how study assets are created and connected across clinical operations. This session will highlight practical GenAI use cases that streamline document creation, reduce cycle times, and improve consistency—from digital CSPs to CSRs. It will explore how Agentic AI can elevate automation across EDC, RBQM, and eTMF processes, driving real operational efficiency. The discussion will close on the key enablers—data standards, libraries, and culture—that make AI-enabled operations sustainable and scalable.

Industrialising Clinical Trials with AI

Photo of Sidharth (Sid) Jain, Senior Vice President, Clinical Development & Data Science, Recursion , SVP, Clinical Development & Data Science at Recursion , Recursion
Sidharth (Sid) Jain, Senior Vice President, Clinical Development & Data Science, Recursion , SVP, Clinical Development & Data Science at Recursion , Recursion

In the session, I'd share share how we're tackling clinical development by leveraging AI/ML and LLMsand with an industrial mindset with specific examples, including improved trial design, execution, and evidence generation.

Panel Moderator:

PANEL DISCUSSION:
Building a Centralised Framework to Enable Smarter Decision-Making

Photo of Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen
Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen

Panelists:

Photo of Bhargava Reddy, PhD, Senior Director, Advanced Insights and Solutions, Janssen , Senior Director, Advanced Insights and Solutions , Advanced Analytics , Janssen Research and Development
Bhargava Reddy, PhD, Senior Director, Advanced Insights and Solutions, Janssen , Senior Director, Advanced Insights and Solutions , Advanced Analytics , Janssen Research and Development

Vijay Singh, Executive Director, Clinical Trials, Novartis Pharma SAS , Executive Director , Clinical Trials , Novartis Pharma SAS

Photo of Anna Majewska, Head of Product Experience, Evinova , Head of Product Experience , Evinova
Anna Majewska, Head of Product Experience, Evinova , Head of Product Experience , Evinova

Reception in the Exhibit Hall with Beer, Wine, and Tapas

Wind down at the end of a busy session day with colleagues, beer, wine, and tapas. Have a drink with your favorite exhibitor and take a chance at winning a fabulous raffle prize (must be present to win)!

Close of Day

Wednesday, 15 October

Registration and Morning Coffee

DIGITAL DATA FLOW AND AGENTIC AI

Data, Data, Everywhere, and Not a Byte to Use

Photo of Nicholas Brooke, Founder and Executive Director, The Synergist , CEO , The Synergist
Nicholas Brooke, Founder and Executive Director, The Synergist , CEO , The Synergist
Photo of Robert DiCicco, Vice President, Portfolio Management, TransCelerate BioPharma, Inc. , Vice President Portfolio Management , TransCelerate BioPharma Inc.
Robert DiCicco, Vice President, Portfolio Management, TransCelerate BioPharma, Inc. , Vice President Portfolio Management , TransCelerate BioPharma Inc.

The Twenty-First Century Cures Act changed the opportunity to leverage electronic health data to improve clinical outcomes and theoretically support regulatory decision-making. Despite its passage over seven years ago that promise has been largely unfulfilled. In the Pharma R&D environment there is limited ability to unlock the potential of that data in a scalable way. Recent advances in technology along with cross sector collaborations there is a renewed opportunity to take another leap forward to accelerate clinical research.

Panel Moderator:

PANEL DISCUSSION:
From Predictive to Proactive: Agentic AI in Clinical Trials

Photo of Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany , Head, Operational Design Center , Merck KGaA, Darmstadt, Germany
Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany , Head, Operational Design Center , Merck KGaA, Darmstadt, Germany

Panelists:

Photo of Prasanna Rao, Chief Products and Innovation Officer, Saama , Chief Products and Innovation Officer , Saama
Prasanna Rao, Chief Products and Innovation Officer, Saama , Chief Products and Innovation Officer , Saama

Justin North, Director Product Management, TriNetX, Inc. , Dir Product Mgmt , Product Mgmt , TriNetX Inc

Coffee Break in the Exhibit Hall

More coffee, more exhibitors, more networking, and some delicious snacks. What’s not to love?

WEDNESDAY MORNING PLENARY SESSION: SCALING SMARTER TRIALS: NETWORKS, AI, AND THE NEW CLINICAL RESEARCH INFRASTRUCTURE

Networking Game, SCOPE Quiz & Prize Giveaway!

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

Chairperson's Remarks

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
Embracing the Power of Networks to Expand Pharma's Research Footprint and Improve Recruitment

Terttu Haring, MD, Global Head, Engagement Strategy (Sites & Patients), Johnson & Johnson Innovative Medicine , Global Head, Engagement Strategy (Sites & Patients) , Johnson & Johnson Innovative Medicine

Panelists:

Javier Carmona, PhD, Head of Scientific Strategy & Translational Programs, Vall d’Hebron Institute of Oncology (VHIO); CSO, Cancer Core Europe , Head of Scientific Strategy, Chief Scientific Officer , Vall d’Hebron Institute of Oncology (VHIO), Cancer Core Europe (CCE)

Astrid Schut, Managing Director, WCN (Werkgroep Cardiologische centra Nederland) , Managing Director , WCN (Werkgroep Cardiologische centra Nederland)

Panel Moderator:

KEYNOTE PANEL DISCUSSION:
AI in Clinical Trials: Where Science Meets Systems—Bridging Operational Expertise with Technical Innovation

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

Panelists:

Jonathan Crowther, PhD, Head, Operational Design Center, Merck KGaA, Darmstadt, Germany , Head, Operational Design Center , Merck KGaA, Darmstadt, Germany

Janie Hansen, Business Systems Transformation, Global Development Information Management, Daiichi Sankyo, Inc. , Business Systems Transformation , Global Development Information Management , Daiichi Sankyo Inc

Francis Kendall, Head of Statistical Programming, Digital and Data Sciences, Biogen , Head of Statistical Programming, Digital and Data Sciences , Biogen

James Weatherall, PhD, Vice President & Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca , VP & Chief Data Scientist , BioPharmaceuticals R&D , AstraZeneca

Join your Peers for a Networking Luncheon in the Exhibit Hall

Join us again for lunch in the Exhibit Hall. Last chance to visit with exhibitors you missed and to enter our final raffle!

RWD MEETS AI

Chairperson's Remarks

Dorothee B. Bartels, PhD, Strategist, Global Real World Evidence and (Gen)AI in Healthcare , Founder HealthData-Advisors , HeDa-Advisors

Harnessing AI and RWD for Clinical Research and Drug Development

Photo of Thirupathi Pattipaka, Global Director, Data Science & Artificial Intelligence, Novartis Pharma AG , Global Director , Data Science & Artificial Intelligence , Novartis Pharma AG
Thirupathi Pattipaka, Global Director, Data Science & Artificial Intelligence, Novartis Pharma AG , Global Director , Data Science & Artificial Intelligence , Novartis Pharma AG

Drug development process is time-consuming, expensive, and success rate is low. This session explores how Artificial Intelligence (AI), combined with Real-World Data (RWD), is revolutionizing clinical research and drug development. The AI-driven methodologies to leverage RWD, enhancing study designs, protocol authoring, and accelerating trial processes. The presentation will also highlight some practical use cases for successfully adopting these transformative technologies in the clinical development and clinical research.

Next-Level Predictive Enrichment of Clinical Trials: Towards AI Characterisation of Patient Subtypes Using a Systems Biology Framework

Photo of Negin Hajizadeh, MD, MPH, RWE Research Principle Scientist, Pulmonary and Critical Care Physician, RWE Center of Excellence, Bayer , Senior IEG Researcher , Bayer
Negin Hajizadeh, MD, MPH, RWE Research Principle Scientist, Pulmonary and Critical Care Physician, RWE Center of Excellence, Bayer , Senior IEG Researcher , Bayer

Heterogeneity of treatment effect is a known barrier to successful clinical trials. Large volumes of RWD may be synthesised within clinically informed systems biology models to characterise patient subtypes, taking into consideration dynamic changes in multiple organs and response to medications, in addition to baseline characteristics. This talk will suggest a framework for pursuing such analyses.

AI Applications in Epidemiological Research for Clinical Development: Scaling Insights, Not Mistakes

Photo of David Vizcaya, Director, Epidemiology, Development, Regulatory and Safety, Alexion Pharmaceuticals , Director , Epidemiology, Development, Regulatory and Safety , Alexion Pharmaceuticals
David Vizcaya, Director, Epidemiology, Development, Regulatory and Safety, Alexion Pharmaceuticals , Director , Epidemiology, Development, Regulatory and Safety , Alexion Pharmaceuticals

My presentation will explore how AI is reshaping epidemiological research for clinical development. With a pragmatic approach, it will discuss how AI may support better data selection, faster cohort building, and smarter outcome prediction. It emphasises strategic benefits and limitations, including potential pitfalls downstream. I expect to offer insights for using AI to drive more efficient and ethical drug development

Panel Moderator:

PANEL DISCUSSION:
Can AI Increase the Value of RWD for Clinical Development and Operations?

Photo of Dorothee B. Bartels, PhD, Strategist, Global Real World Evidence and (Gen)AI in Healthcare , Founder HealthData-Advisors , HeDa-Advisors
Dorothee B. Bartels, PhD, Strategist, Global Real World Evidence and (Gen)AI in Healthcare , Founder HealthData-Advisors , HeDa-Advisors

Panelists:

Photo of Negin Hajizadeh, MD, MPH, RWE Research Principle Scientist, Pulmonary and Critical Care Physician, RWE Center of Excellence, Bayer , Senior IEG Researcher , Bayer
Negin Hajizadeh, MD, MPH, RWE Research Principle Scientist, Pulmonary and Critical Care Physician, RWE Center of Excellence, Bayer , Senior IEG Researcher , Bayer
Photo of David Vizcaya, Director, Epidemiology, Development, Regulatory and Safety, Alexion Pharmaceuticals , Director , Epidemiology, Development, Regulatory and Safety , Alexion Pharmaceuticals
David Vizcaya, Director, Epidemiology, Development, Regulatory and Safety, Alexion Pharmaceuticals , Director , Epidemiology, Development, Regulatory and Safety , Alexion Pharmaceuticals
Photo of Thirupathi Pattipaka, Global Director, Data Science & Artificial Intelligence, Novartis Pharma AG , Global Director , Data Science & Artificial Intelligence , Novartis Pharma AG
Thirupathi Pattipaka, Global Director, Data Science & Artificial Intelligence, Novartis Pharma AG , Global Director , Data Science & Artificial Intelligence , Novartis Pharma AG

Session Break

WEDNESDAY AFTERNOON PLENARY SESSION: THE FUTURE WE BUILD: RECOGNISING INNOVATION, RESTORING EUROPE’S ROLE, AND RECLAIMING THE PATIENT VOICE

Grab Your Seat: Plenary Keynote Seat Raffle & Prize Giveaway! (Sponsorship Opportunity Available)

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

CLINICAL RESEARCH NEWS' BEST-OF-SHOW AWARD:
Recognising Exceptional Innovation in Technologies Used by Clinical Research Professionals

Allison Proffitt, Editorial Director, Bio-IT World and Clinical Research News , Editorial Dir , Bio-IT World

Sponsored by Clinical Research News & ClinEco
The 2025 Best-of-Show Awards offer exhibitors of the SCOPE Summit Europe an exclusive opportunity to distinguish and highlight their products, including innovative applications, technologies, tools, and solutions. The SCOPE community is invited to identify exceptional innovation in technologies used by life-science professionals, voting on the most impactful new products of the year. Submit your entry! https://www.scopesummiteurope.com/sponsor-exhibitor/best-of-show-awards

KEYNOTE FIRESIDE CHAT:
Trials Are Leaving Europe—Can We Bring Them Back?

Moe Alsumidaie, Chief Editor, Editorials, Clinical Trial Vanguard , Chief Editor , Editorials , Clinical Trial Vanguard

Adama Ibrahim, Vice President, Digital Strategy & Change Management, Novo Nordisk , VP Digital Strategy and Change Management , Digital Science & Innovation , Novo Nordisk

Tero Laulajainen, Vice President, Head of Global Clinical Operations, UCB , VP - Global Clinical Science and Operations , Head of Global Clinical Operations , UCB

This keynote panel will address the decline in clinical trial activity across the European Union and what it will take to reverse the trend. Topics will include ethics review fragmentation, trial startup delays, cost pressures, site performance, and underrepresentation of EU citizens in global clinical trial data. The panel will explore how regulatory guidance, public-private collaboration, and ACT EU can collectively restore Europe's competitiveness in clinical development.

KEYNOTE FIRESIDE CHAT:
Patient Engagement to Shape Trial Design and Operations around Unmet Patients’ Needs

Alfonso Aguarón, Patient Advocate; Patient Engagement Director, Patvocates , Patient Engagement Director , Patvocates

Gonzalo Linares, Senior Director & Global Head, Patient Advocacy & External Engagement R&D, Johnson & Johnson AG , Senior Director, Global Head Patient Advocacy R&D , Patient Advocacy & External Engagement R&D , Johnson & Johnson AG

This dynamic session brings together the voices of industry and patients to explore how meaningful patient engagement can transform clinical trial design and execution. A pharma leader and a patient advocate will share real-world examples of collaboration that led to more inclusive protocols, improved recruitment, and enhanced trial experiences. Attendees will gain practical insights into embedding patient perspectives early and often to address unmet needs and drive better outcomes. Join us to learn how co-creating with patients is not just the right thing to do—it’s a strategic imperative.

Closing Remarks and Next Steps

Micah Lieberman, Executive Director, SCOPE, Cambridge Healthtech Institute; Co-Founder, ClinEco , Executive Director , Cambridge Healthtech Institute

Close of Conference

For more details on the conference, please contact:

Marina Filshtinsky, MD

Executive Director

Cambridge Healthtech Institute

Phone: (+1) 617-276-5018

Email: mfilshtinsky@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-E:

Ilana Quigley

Director, Sales

Cambridge Healthtech Institute

Phone: (+1) 781-972-5457

Email: iquigley@healthtech.com

 

Companies F-N:

Katelin Fitzgerald

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-1824

Email: kfitzgerald@cambridgeinnovationinstitute.com

 

Companies O-V:

Jon Stroup

Lead Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483

Email: jons@healthtech.com

 

Companies W-Z:

Patty Rose

Vice President, Sales

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-1349

Email: prose@healthtech.com

 

For media and association partnerships, please contact:

Rich Handy

Associate Vice President, Marketing

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781-972-5456

Email: rhandy@healthtech.com